IMPACT OF BASELINE KIDNEY FUNCTION ON SGLT2 INHIBITOR EFFECTS ON RENAL AND HEART FAILURE OUTCOMES: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

被引：0
|
作者：
Cavallari, Ilaria [1 ]
La Porta, Ylenia [1 ]
Maddaloni, Ernesto [2 ]
Appetecchia, Alessandro [1 ]
D'onofrio, Luca [2 ]
Grigioni, Francesco [1 ]
机构：
[1] Campus Biomed Univ Rome, Dept Cardiovasc Sci, Rome, Italy
[2] Sapienza Univ Rome, Dept Expt Med, Rome, Italy
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2022年 / 24卷
关键词：
D O I：
10.1093/eurheartjsupp/suac121.461
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
261
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Long-term surrogate cardiovascular outcomes of SGLT2 inhibitor empagliflozin in chronic heart failure: a systematic review and meta-analysis
    Yan, Qingkai
    Chen, Xinrao
    Yu, Changqing
    Yin, Yuehui
    BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01):
  • [42] Kidney outcomes using a sustained ≥40% decline in eGFR: A meta-analysis of SGLT2 inhibitor trials
    Cherney, David Z., I
    Dagogo-Jack, Samuel
    McGuire, Darren K.
    Cosentino, Francesco
    Pratley, Richard
    Shih, Weichung J.
    Frederich, Robert
    Maldonado, Mario
    Liu, Jie
    Wang, Shuai
    Cannon, Christopher P.
    CLINICAL CARDIOLOGY, 2021, 44 (08) : 1139 - 1143
  • [43] Cardiovascular Outcomes with SGLT-2 inhibitors in patients with heart failure with or without type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials
    Singh, Awadhesh Kumar
    Singh, Ritu
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2021, 15 (01) : 351 - 359
  • [44] Impact of SGLT2 inhibition on markers of reverse cardiac remodelling in heart failure: Systematic review and meta-analysis
    Savage, Patrick
    Watson, Chris
    Coburn, Jaimie
    Cox, Brian
    Shahmohammadi, Michael
    Grieve, David
    Dixon, Lana
    ESC HEART FAILURE, 2024, 11 (06): : 3636 - 3648
  • [45] CARDIORENAL OUTCOMES OF EMPAGLIFLOZIN IN ACUTE HEART FAILURE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Borges, Rafael
    Navalha, Denilsa
    Oliveira, Gustavo
    Alves, Vinicius
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 563 - 563
  • [46] Effects of SGLT2 Inhibitor on Ischemic Events Stemming From Atherosclerotic Coronary Diseases: A Systematic Review and Meta-analysis With Trial Sequential Analysis of Randomized Controlled Trials
    Ye, Gailin
    Wang, Shuai
    Peng, Daoquan
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2021, 77 (06) : 787 - 795
  • [47] Systematic Review and Meta-Analysis of Randomized Controlled Trials on the Effect of SGLT2 Inhibitor on Blood Leptin and Adiponectin Level in Patients with Type 2 Diabetes
    Wu, Peili
    Wen, Weiheng
    Li, Jitong
    Xu, Jie
    Zhao, Min
    Chen, Hong
    Sun, Jia
    HORMONE AND METABOLIC RESEARCH, 2019, 51 (08) : 487 - 494
  • [48] SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials
    Li, Wen-jie
    Chen, Xing-qing
    Xu, Ling-ling
    Li, Yuan-qing
    Luo, Bi-hui
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [49] SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials
    Wen-jie Li
    Xing-qing Chen
    Ling-ling Xu
    Yuan-qing Li
    Bi-hui Luo
    Cardiovascular Diabetology, 19
  • [50] EFFICACY AND SAFETY OF SGLT2 INHIBITORS IN ACUTE DECOMPENSATED HEART FAILURE: A META-ANALYSIS OF RANDOMIZED TRIALS
    Khan, Muhammad Aslam
    Khan, Syed Zamrak
    Alkhalfan, Fahad
    Rahman, Hammad
    Lamichhane, Bikal
    Akbar, Usman
    Sharma, Saurabh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 533 - 533
12345